Editor in Chief

Dr. Thomas Santoro received the MD degree at New York University School of Medicine.  He did his internship and residency at Duke University Medical Center in Durham, NC.  After completing training in Internal Medicine, Dr. Santoro did an Arthritis Foundation Fellowship at Duke where his research focused on the study of autoimmune diseases.  He then spent 3 years at the Arthritis Branch of…

Name : Dr. Thomas Santoro
University : University of Illinois College of Medicine

Indexing and Listing

          

Recent Articles

  • article image

    Does Bodily Temperature Explain the Differential Incidence of Gonadal Burkitt Tumor?

    Whereas the ovary lies within the warm depth of the pelvis, its homologous counterpart, the testis, hangs coolly outside on account of the natural function of the cremaster muscles of the scrotum. Therefore, it is epidemiologically unique that 18 cases of ovarian Burkitt tumor were found against one testicular case in a 30-year biopsy series obtained…

    View more
  • article image

    Gastric Amyloidosis Mimicking a Gastric Neoplasm

    We present this case to highlight the importance of considering an infiltrative systemic disorder for gastrointestinal symptoms and weight loss. We want to emphasize that amyloidosis, although rare, can initially present with predominantly gastrointestinal symptoms alone. It is important for the internist and gastroenterologist to consider amyloidosis…

    View more
  • article image

    Breast Cancer in a Patient with Neurofibromatosis Type 1: A Case Report & Review Literature

    Neurofibromatosis type I (NF1) is one of the most common genetic diseases in humans. It is associated with various benign and malignant tumors, including breast cancer. Various studies conducted in the last few years implicated an increased risk of breast cancer in NF1 patients. However, association between NF1and breast cancers is recognized only…

    View more

PubMed Indexed Articles

  • article image

    Homeodomain Transcription Factor Msx-2 Regulates Uterine Progenitor Cell Response to Diethylstilbestrol

    The fate of mouse uterine epithelial progenitor cells is determined between postnatal days 5 to 7. Around this critical time window, exposure to an endocrine disruptor, diethylstilbestrol (DES), can profoundly alter uterine cytodifferentiation. We have shown previously that a homeo domain transcription factor MSX-2 plays an important role in DES-responsiveness…

    View more
  • article image

    Brain Uptake of Neurotherapeutics after Intranasal Delivery in Mice

    There is a growing global prevalence of neurodegenerative diseases such as Alzheimer’s disease and dementia. Current treatment for neurodegenerative diseases is limited due to the blood brain barrier’s ability to restrict the entry of therapeutics to the brain. In that context, direct delivery of drugs from nose to brain has gained emerging interest…

    View more
  • article image

    Current Studies of Immunotherapy on Glioblastoma

    Glioblastoma is a form of brain tumor with a very high morbidity and mortality. Despite decades of research, the best treatments currently in clinical practice only extend survival by a number of months. A promising alternative to conventional treatment for glioblastomas is immunotherapy. Although proposed over a century ago, the field of cancer immunotherapy…

    View more

Podcast

Testimonial

Paul G Mathew, Harvard Vanguard Medical Associates

It was a pleasure to publish my manuscript with the Journal of Neurology and Neurosurgery. I found the peer review process was rigorous, and helped to improve the overall quality of my manuscript without being too tedious. The editorial staff, particularly Divakar Sadam, was very responsive to all of my concerns, and usually corresponded within 24 hours of a query. I had an overall excellent experience, and I hope that the journal is indexed in PubMed in the near future.